Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.295 USD | -0.38% | +2.78% | -14.24% |
Business Summary
Number of employees: 3,930
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostics
59.7
%
| 756 | 75.2 % | 515 | 59.7 % | -31.81% |
Pharmaceutical
40.3
%
| 249 | 24.8 % | 348 | 40.3 % | +40.09% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
69.2
%
| 783 | 78.0 % | 598 | 69.2 % | -23.67% |
Ireland
16.4
%
| 117 | 11.7 % | 141 | 16.4 % | +20.69% |
Chile
7.9
%
| 62 | 6.2 % | 68 | 7.9 % | +10.39% |
Spain
2.7
%
| 22 | 2.2 % | 24 | 2.7 % | +4.63% |
Mexico
2.3
%
| 15 | 1.4 % | 20 | 2.3 % | +38.98% |
Israel
1.1
%
| 4 | 0.4 % | 10 | 1.1 % | +153.26% |
Other
0.3
%
| 1 | 0.1 % | 2 | 0.3 % | +160.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 27/07/27 |
Adam Logal
DFI | Director of Finance/CFO | 46 | 01/07/01 |
Elias Zerhouni
PSD | President | 72 | 09/22/09 |
Elizabeth Nabel
CTO | Chief Tech/Sci/R&D Officer | 72 | 01/22/01 |
Jane Hsaio
CTO | Chief Tech/Sci/R&D Officer | 77 | 01/07/01 |
Steven Rubin
ADM | Chief Administrative Officer | 63 | 01/07/01 |
Gary Nabel
BRD | Director/Board Member | 70 | 09/22/09 |
Jane Pine Wood
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | 09/14/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 27/07/27 |
Roger Medel
BRD | Director/Board Member | 77 | 18/20/18 |
Director/Board Member | 68 | 01/08/01 | |
Steven Rubin
ADM | Chief Administrative Officer | 63 | 01/07/01 |
Lin-Tsing Yu
BRD | Director/Board Member | 80 | 23/09/23 |
Jane Hsaio
CTO | Chief Tech/Sci/R&D Officer | 77 | 01/07/01 |
John Paganelli
BRD | Director/Board Member | 89 | 01/03/01 |
Richard Krasno
BRD | Director/Board Member | 82 | 09/17/09 |
Elias Zerhouni
PSD | President | 72 | 09/22/09 |
Gary Nabel
BRD | Director/Board Member | 70 | 09/22/09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 705,646,759 | 331,723,053 ( 47.01 %) | 8,655,082 ( 1.227 %) | 47.01 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GENEDX HOLDINGS CORP. 13.66% | 3,558,601 | 13.66% | 32,490,027 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.24% | 906M | |
-18.58% | 8.15B | |
+47.89% | 3.82B | |
-8.06% | 2.47B | |
-38.71% | 2.46B | |
-10.06% | 2.34B | |
-6.67% | 1.88B | |
-17.29% | 1.55B | |
-40.78% | 1.21B | |
+7.82% | 1.11B |
- Stock Market
- Equities
- OPK Stock
- Company OPKO Health, Inc.